SCHEMBL5659889

SCHEMBL5659889

NC(=O)C1CC(N2CCNCC2)CCN1C(=O)[CH]Cc1ccc2[nH]ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.40
PARP2 Q9UGN5 1/20 0.40
CCR3 P51677 2/20 0.38
CHRM2 P08172 1/20 0.36
CALCRL Q16602 2/20 0.34
CYP3A4 P08684 1/20 0.34
FAAH O00519 1/20 0.33
SLC6A2 P23975 4/20 0.32
SLC6A4 P31645 4/20 0.32
SLC6A3 Q01959 4/20 0.32
CHRNA7 P36544 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MCHR1 Q99705 2/20 0.32
KCNH2 Q12809 1/20 0.32
MCHR2 Q969V1 1/20 0.32
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5657887 0.86 CYP3A4 (0.35) CALCRLCYP3A4SLC6A2SLC6A4SLC6A3
SCHEMBL5660887 0.84 PARP1 (0.38) PARP1PARP2CCR3CHRM2CALCRL
SCHEMBL5659610 0.83 CALCRL (0.36) CALCRLCYP3A4SLC6A2SLC6A4SLC6A3
SCHEMBL5656765 0.82
SCHEMBL5659937 0.77 CALCA (0.32)
SCHEMBL5658670 0.77 CALCRL (0.35) CALCRLCYP3A4
SCHEMBL5660912 0.76 CCR3 (0.47) PARP1PARP2CCR3CHRM2CALCRL
SCHEMBL5660300 0.76 CCR3 (0.47) PARP1PARP2CCR3CHRM2CALCRL
SCHEMBL3602596 0.71 CYP2D6 (0.41) SLC6A2SLC6A4SLC6A3SIGMAR1
SCHEMBL5657432 0.71 CHRNA7 (0.43) PARP1PARP2CCR3CHRM2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227968-A1 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-10-13 US claimed
US-7205294-B2 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-04-17 US disclosed
US-20050227968-A1 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227968-A1 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions BDKRB1, BDKRB2, CALCRL PARP1 2770/4885PARP2 2617/4885CCR3 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.